Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.

Oktenli, Cagatay

Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. [electronic resource] - Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology Dec 2007 - 710-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0951-3590

10.1080/09513590701666571 doi


Acylation--drug effects
Adult
Body Mass Index
Case-Control Studies
Complement C3a--drug effects
Female
Humans
Hypoglycemic Agents--pharmacology
Metformin--pharmacology
Polycystic Ovary Syndrome--drug therapy